5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.19▼ | 1.19▼ | 1.19▼ | 1.15▼ | 1.69▼ |
MA10 | 1.16▼ | 1.17▼ | 1.16▼ | 1.13▲ | 2.83▼ |
MA20 | 1.17▼ | 1.16▼ | 1.16▼ | 2.12▼ | 3.91▼ |
MA50 | 1.29▼ | 1.85▼ | 2.26▼ | 3.32▼ | 6.23▼ |
MA100 | 1.41▼ | 2.74▼ | 3.06▼ | 4.19▼ | 8.86▼ |
MA200 | 2.36▼ | 3.71▼ | 4.12▼ | 5.73▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.013▲ | 0.059▲ | 0.085▲ | -0.020▼ | -0.249▼ |
RSI | 44.476▼ | 35.838▼ | 31.619▼ | 25.199▼ | 22.113▼ |
STOCH | 68.727 | 65.336 | 57.945 | 26.611 | 14.008▼ |
WILL %R | -66.667 | -66.667 | -70.588 | -95.331▼ | -97.285▼ |
CCI | -6.986 | -10.812 | -17.853 | -42.557 | -130.556▼ |
Sunday, July 03, 2022 11:52 PM
Addex Therapeutics Ltd (NASDAQ:ADXN – Get Rating) was the target of a significant increase in short interest during the month of June. As of June 15th, there was short interest totalling 3,100 shares, ...
|
Thursday, June 30, 2022 10:50 AM
1 Day ADXN 11.43% DJIA -0.52% Russell 2K -0.32% Health Care/Life Sciences -0.12% ...
|
Tuesday, June 28, 2022 05:00 PM
There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
06/07/22 | 1.15 | 1.15 | 1.15 | 1.15 | 11,903 |
05/07/22 | 1.20 | 1.29 | 1.10 | 1.20 | 248,091 |
01/07/22 | 1.21 | 1.22 | 1.12 | 1.19 | 62,499 |
30/06/22 | 1.1831 | 1.1964 | 1.05 | 1.15 | 82,808 |
29/06/22 | 1.14 | 1.14 | 1.03 | 1.085 | 34,867 |
28/06/22 | 1.15 | 1.15 | 1.05 | 1.05 | 55,568 |
27/06/22 | 1.07 | 1.14 | 1.07 | 1.1294 | 38,310 |
24/06/22 | 1.13 | 1.18 | 1.05 | 1.10 | 45,200 |
23/06/22 | 1.15 | 1.31 | 1.0938 | 1.14 | 127,694 |
22/06/22 | 1.26 | 1.26 | 1.05 | 1.1068 | 106,315 |
|
|
||||
|
|
||||
|
|